Promotions & Moves

Enterprise Therapeutics Appoints CEO

Ford is a biotechnology entrepreneur with 18 years of drug discovery and development experience

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Dr. John Ford has been appointed chief executive officer of Enterprise Therapeutics. The company is developing novel muco-regulatory therapies for Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis (CF) and severe asthma.   Dr. Ford has more than 18 years of ion channel research, drug discovery and development experience. He is a biotechnology entrepreneur who co-founded Xention, Ario Pharma and Metrion Biosciences. Recently, he was a member of the executive team at Dezima, which de...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters